Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06657716 · ClinicalTrials.gov registry record
Heidelberg Engineering ANTERION Software Comparison Study
A clinical trial of Eyes With Normal Anterior Segment and Eyes With Abnormal Anterior Segment, sponsored by Heidelberg Engineering.
- Active
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06657716 is a study of Eyes With Normal Anterior Segment and Eyes With Abnormal Anterior Segment that is active but no longer recruiting, run by Heidelberg Engineering. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06657716, a study of Eyes With Normal Anterior Segment and Eyes With Abnormal Anterior Segment, is active but no longer recruiting, sponsored by Heidelberg Engineering.
- ACTIVE NOT RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)
Conditions Studied
Interventions
- DEVICE ANTERION investigational
Study Locations (1)
Minnesota
- Fischer Eye Laser Center - Wilmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-10-02 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06657716
The ClinicalTrials.gov registry entry for NCT06657716 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Eyes With Normal Anterior Segment appearing as the primary indexed condition, and to 1 intervention - of which ANTERION investigational is the first listed.
NCT06657716 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06657716 about?
NCT06657716 is a clinical study titled "Heidelberg Engineering ANTERION Software Comparison Study". This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)
What is the current status of trial NCT06657716?
This trial is currently active not recruiting. The enrollment target is 60 participants. The study started on 2024-10-02. Estimated completion is 2026-10.
What conditions does trial NCT06657716 study?
This clinical trial studies the following conditions: Eyes With Normal Anterior Segment, Eyes With Abnormal Anterior Segment.
What interventions are being tested in trial NCT06657716?
The interventions under investigation include: ANTERION investigational (DEVICE).
Who is sponsoring clinical trial NCT06657716?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06657716 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Eyes With Normal Anterior Segment
All registered trials for this condition
Eyes With Abnormal Anterior Segment
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.